dehydroepiandrosterone has been researched along with Vulvovaginitis in 2 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Vulvovaginitis: Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The use of estrogen agonists/antagonists and intravaginal dehydroepiandrosterone (DHEA) have both been shown to positively affect vaginal atrophy symptoms without inducing endometrial proliferation." | 4.86 | Vulvovaginal atrophy: current and future therapies (CME). ( Ibe, C; Simon, JA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibe, C | 1 |
| Simon, JA | 1 |
| Phillips, TJ | 1 |
| Demircay, Z | 1 |
| Sahu, M | 1 |
2 reviews available for dehydroepiandrosterone and Vulvovaginitis
| Article | Year |
|---|---|
Vulvovaginal atrophy: current and future therapies (CME).
Topics: Adjuvants, Immunologic; Aged; Atrophy; Dehydroepiandrosterone; Drug Administration Schedule; Drug Th | 2010 |
Hormonal effects on skin aging.
Topics: Dehydroepiandrosterone; Estrogens; Female; Growth Hormone; Hormone Replacement Therapy; Hot Flashes; | 2001 |